PABGX
Price
$185.77
Change
+$0.04 (+0.02%)
Updated
Jan 30 closing price
Net Assets
65.64B
VIGIX
Price
$216.18
Change
+$0.23 (+0.11%)
Updated
Jan 30 closing price
Net Assets
284.41B
Ad is loading...

PABGX vs VIGIX

Header iconPABGX vs VIGIX Comparison
Open Charts PABGX vs VIGIXBanner chart's image
T. Rowe Price Blue Chip Growth Advisor
Price$185.77
Change+$0.04 (+0.02%)
VolumeN/A
Net Assets65.64B
Vanguard Growth Index Institutional
Price$216.18
Change+$0.23 (+0.11%)
VolumeN/A
Net Assets284.41B
PABGX vs VIGIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PABGX vs. VIGIX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PABGX is a Buy and VIGIX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIGIX has more cash in the bank: 284B vs. PABGX (65.6B). VIGIX pays higher dividends than PABGX: VIGIX (0.53) vs PABGX (0.00). PABGX was incepted earlier than VIGIX: PABGX (25 years) vs VIGIX (27 years). PABGX is a more actively managed with annual turnover of: 9.80 vs. VIGIX (5.00). PABGX has a lower initial minimum investment than VIGIX: PABGX (2500) vs VIGIX (5000000). VIGIX annual gain was more profitable for investors over the last year : 31.99 vs. PABGX (23.93). VIGIX return over 5 years is better than : 123.37 vs. PABGX (48.57).
PABGXVIGIXPABGX / VIGIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence25 years27 years-
Gain YTD3.1882.235143%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets65.6B284B23%
Annual Yield % from dividends0.000.53-
Returns for 1 year23.9331.9975%
Returns for 3 years19.8744.3045%
Returns for 5 years48.57123.3739%
Returns for 10 years175.99306.1557%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BZUN3.350.29
+9.48%
Baozun
FORM39.830.86
+2.21%
FormFactor
INDP0.940.02
+1.63%
Indaptus Therapeutics
NTNX68.010.25
+0.37%
Nutanix
HGTY9.74N/A
N/A
Hagerty